Table 4.
Categorized comorbidities of the BaSAlt cohort.
| Women (n = 49) | Men (n = 17) | |
|---|---|---|
| (1) Past cardiovascular event | 24.5% (n = 12) | 47.1% (n = 8) |
| (2) Arterial hypertension | 69.4% (n = 34) | 64.7% (n = 11) |
| (3) Coronary heart disease | 14.3% (n = 7) | 41.2% (n = 7) |
| (4) Cardiac insufficiency | 22.4% (n = 11) | 58.8% (n = 10) |
| (5) Cardiac pacemakers | 6.1% (n = 3) | 17.6% (n = 3) |
| (6) Post-stroke/cerebral hemorrhage/TIA | 26.5% (n = 13) | 29.4% (n = 5) |
| (7) Chronic lung disease | 8.2% (n = 4) | 11.8% (n = 2) |
| (8) Cancer | 12.2% (n = 6) | 29.4% (n = 5) |
| (9) Diabetes mellitus type II | 20.4% (n = 10) | 29.4% (n = 5) |
| (10) Osteoarthritis lower extremity | 26.5% (n = 13) | 23.5% (n = 4) |
| (11) Psychological/emotional/nervous disease | 57.1% (n = 28) | 64.7% (n = 11) |